AAAAAA
Results: 1-25/75
Authors:
Podder, H
Stepkowski, SM
Napoli, KL
Clark, J
Verani, RR
Chou, TC
Kahan, BD
Citation: H. Podder et al., Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations, J AM S NEPH, 12(5), 2001, pp. 1059-1071
Authors:
Podder, H
Podbielski, J
Hussein, I
Katz, S
Van Buren, C
Kahan, BD
Citation: H. Podder et al., Sirolimus improves the two-year outcome of renal allografts in African-American patients, TRANSPLAN I, 14(3), 2001, pp. 135-142
Authors:
Portman, RJ
Meier-Kriesche, HU
Swinford, R
Brannan, P
Kahan, BD
Citation: Rj. Portman et al., Reduced variability of Neoral pharmacokinetic studies in pediatric renal transplantation (vol 15, pg 2, 2000), PED NEPHROL, 16(3), 2001, pp. 309-309
Authors:
Mahalati, K
Kahan, BD
Citation: K. Mahalati et Bd. Kahan, Clinical pharmacokinetics of sirolimus, CLIN PHARMA, 40(8), 2001, pp. 573-585
Authors:
Kirken, RA
Erwin-Cohen, R
Behbod, F
Wang, ME
Stepkowski, SM
Kahan, BD
Citation: Ra. Kirken et al., Tyrphostin AG490 selectively inhibits activation of the JAK3/STAT5/MAPK pathway and rejection of rat heart allografts, TRANSPLAN P, 33(1-2), 2001, pp. 95-95
Authors:
Stepkowski, SM
Kirken, RA
Wang, M
Yu, J
Akioka, K
Kahan, BD
Citation: Sm. Stepkowski et al., Tolerance induction by alteration of T cell receptor (TCR) signaling usingan allochimeric donor/recipient class I MHC protein, TRANSPLAN P, 33(1-2), 2001, pp. 131-131
Authors:
Wang, ME
Kirken, R
Behbod, F
Erwin-Cohen, R
Stepkowski, SM
Kahan, BD
Citation: Me. Wang et al., Inhibition of Jak3 tyrosine kinase by PNU156804 blocks rat heart allograftrejection, TRANSPLAN P, 33(1-2), 2001, pp. 201-201
Authors:
Kerman, RH
Katz, SM
Van Buren, CT
Garcia, C
Kahan, BD
Citation: Rh. Kerman et al., Addition of rapamycin to cyclosporine-prednisone based immunosuppression reduces the clinical risk of pretransplant anti-HLA antibody, TRANSPLAN P, 33(1-2), 2001, pp. 401-401
Authors:
Kerman, RH
Katz, SM
Van Buren, CT
Ruth, J
McKissick, E
Rasmussen, S
Kahan, BD
Citation: Rh. Kerman et al., Posttransplant immune monitoring of anti-HLA antibody, TRANSPLAN P, 33(1-2), 2001, pp. 402-402
Authors:
Gebel, HM
Bray, RA
Ruth, JA
Zibari, GB
McDonald, JC
Kahan, BD
Kerman, RH
Citation: Hm. Gebel et al., Flow PRA to detect clinically relevant HLA antibodies, TRANSPLAN P, 33(1-2), 2001, pp. 477-477
Authors:
Chen, W
Bennett, CF
Condon, TP
Stecker, K
Tian, L
Kahan, BD
Stepkowski, SM
Citation: W. Chen et al., Methoxyethyl modification of phosphorothioate ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury, TRANSPLAN P, 33(1-2), 2001, pp. 854-854
Authors:
Troncoso, P
Ortiz, M
Martinez, L
Kahan, BD
Citation: P. Troncoso et al., FTY 720 prevents ischemic reperfusion damage in ret kidneys, TRANSPLAN P, 33(1-2), 2001, pp. 857-859
Authors:
Hong, JC
Kahan, BD
Citation: Jc. Hong et Bd. Kahan, Sirolimus rescue therapy for refractory rejection in renal transplant recipients, TRANSPLAN P, 33(1-2), 2001, pp. 1033-1033
Authors:
Podder, H
Stepkowski, SM
Napoli, K
Kahan, BD
Citation: H. Podder et al., Pharmacokinetic interactions between sirolimus and cyclosporine exacerbaterenal dysfunction, TRANSPLAN P, 33(1-2), 2001, pp. 1086-1086
Authors:
Podder, H
Podbielski, J
Hussein, I
Katz, SM
Van Buren, CT
Kahan, BD
Citation: H. Podder et al., Impact of sirolimus on renal transplant outcomes in African Americans, TRANSPLAN P, 33(1-2), 2001, pp. 1226-1226
Authors:
Mahalati, K
Kahan, BD
Citation: K. Mahalati et Bd. Kahan, Sirolimus permits steroid withdrawal from a cyclosporine regimen, TRANSPLAN P, 33(1-2), 2001, pp. 1270-1270
Authors:
Hong, JC
Kahan, BD
Citation: Jc. Hong et Bd. Kahan, A calcineurin antagonist-free induction immunosuppression strategy for delayed graft function in renal transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1271-1272
Authors:
Kahan, BD
Napoli, KL
Podbielski, J
Hussein, I
Katz, SH
Van Buren, CT
Citation: Bd. Kahan et al., Therapeutic drug monitoring of sirolimus for optimal renal transplant outcomes, TRANSPLAN P, 33(1-2), 2001, pp. 1278-1278
Authors:
Kahan, BD
Camardo, JS
Citation: Bd. Kahan et Js. Camardo, Rapamycin: Clinical results and future opportunities, TRANSPLANT, 72(7), 2001, pp. 1181-1193
Authors:
Hoogeveen, RC
Ballantyne, CM
Pownall, HJ
Opekun, AR
Hachey, DL
Jaffe, JS
Oppermann, S
Kahan, BD
Morrisett, JD
Citation: Rc. Hoogeveen et al., Effect of sirolimus on the metabolism of ApoB100-containing lipoproteins in renal transplant patients, TRANSPLANT, 72(7), 2001, pp. 1244-1250
Authors:
Hong, JC
Kahan, BD
Citation: Jc. Hong et Bd. Kahan, A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients at risk for delayed graft function, TRANSPLANT, 71(9), 2001, pp. 1320-1328
Authors:
Kahan, BD
Citation: Bd. Kahan, Potential therapeutic interventions to avoid or treat chronic allograft dysfunction, TRANSPLANT, 71(11), 2001, pp. SS52-SS57
Authors:
Hong, JC
Kahan, BD
Citation: Jc. Hong et Bd. Kahan, Sirolimus rescue therapy for refractory rejection in renal transplantation, TRANSPLANT, 71(11), 2001, pp. 1579-1584
Authors:
Bai, S
Brunner, LJ
Stepkowski, SM
Napoli, KL
Kahan, BD
Citation: S. Bai et al., Effect of low dose cyclosporine and sirolimus on hepatic drug metabolism in the rat, TRANSPLANT, 71(11), 2001, pp. 1585-1592
Authors:
Kahan, BD
Kaplan, B
Lorber, MI
Winkler, M
Cambon, N
Boger, RS
Citation: Bd. Kahan et al., RAD in de novo renal transplantation: Comparison of three doses on the incidence and severity of acute rejection, TRANSPLANT, 71(10), 2001, pp. 1400-1406